Cedar Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-29,258
Closed -$3.04M 128
2020
Q3
$3.04M Buy
29,258
+9,275
+46% +$931K 1.01% 36
2020
Q2
$1.83M Buy
19,983
+686
+4% +$65.8K 0.7% 52
2020
Q1
$1.74M Sell
19,297
-1,517
-7% -$161K 0.82% 36
2019
Q4
$2.36M Buy
20,814
+4,160
+25% +$456K 1.09% 17
2019
Q3
$1.81M Buy
16,654
+2,985
+22% +$311K 0.85% 30
2019
Q2
$1.33M Sell
13,669
-585
-4% -$53.4K 0.57% 42
2019
Q1
$1.3M Buy
14,254
+299
+2% +$26.8K 0.57% 43
2018
Q4
$1.27M Sell
13,955
-3,902
-22% -$365K 0.64% 36
2018
Q3
$1.76M Buy
17,857
+5,451
+44% +$504K 0.68% 32
2018
Q2
$1.06M Buy
12,406
+3,451
+39% +$288K 0.47% 51
2018
Q1
$718K Buy
8,955
+2,870
+47% +$237K 0.33% 54
2017
Q4
$491K Buy
6,085
+1,286
+27% +$103K 0.24% 63
2017
Q3
$373K Buy
4,799
+200
+4% +$16.6K 0.18% 69
2017
Q2
$408K Buy
4,599
+1,191
+35% +$100K 0.18% 43
2017
Q1
$275K Sell
3,408
-215
-6% -$16.8K 0.11% 68
2016
Q4
$258K Sell
3,623
-900
-20% -$70.7K 0.1% 72
2016
Q3
$391K Sell
4,523
-1,021
-18% -$89K 0.14% 56
2016
Q2
$481K Sell
5,544
-972
-15% -$78.6K 0.16% 50
2016
Q1
$489K Sell
6,516
-6
-0.1% -$452 0.14% 50
2015
Q4
$502K Buy
+6,522
New +$491K 0.11% 50

Other funds holding MDT

Cedar Capital's MDT Position: Q4 2020 in Review

Cedar Capital sold out of Medtronic (MDT) in Q4 2020, closing a stake of 29,258 shares — an estimated $3.04M sold.

Cedar Capital first reported a position in MDT in Q4 2015 and held it in 20 quarters. The position peaked at $3.04M in Q3 2020. 1,957 funds tracked by Wall St. Rank hold MDT as of Q4 2020.

  • Cedar Capital reported no remaining Medtronic position as of Q4 2020 after selling out during the quarter.
  • Cedar Capital sold 29,258 Medtronic shares in Q4 2020, an estimated $3.04M.
  • Cedar Capital first reported a position in Medtronic in Q4 2015 and held it in 20 quarters.
  • Cedar Capital's Medtronic position peaked at $3.04M in Q3 2020.
  • 1,957 funds tracked by Wall St. Rank held Medtronic as of Q4 2020.

Based on Cedar Capital's 13F filing for Q4 2020, filed 5 Feb 2021.